Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
The British Journal of Dermatology
|
March 3, 2020
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study
A V Marzano, G Genovese, G Casazza, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 12, 2019
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
K Peris, A Lo Schiavo, G Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 7, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy
L Sacchelli, F Filippi, A Balato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 1, 2020
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy
M Talamonti, M Galluzzo, A Chiricozzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study
C Bonifati, S Lembo, A G Richetta, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 19, 2024
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment
C C Zouboulis, F G Bechara, F Benhadou, et al.
The Journal of Dermatological Treatment
|
August 20, 2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)
D Orsini, M Megna, C Assorgi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study
B M Piraccini, F Pampaloni, S Cedirian, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
The British Journal of Dermatology
|
March 3, 2020
Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study
A V Marzano, G Genovese, G Casazza, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 12, 2019
HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
K Peris, A Lo Schiavo, G Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 7, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy
L Sacchelli, F Filippi, A Balato, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 1, 2020
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy
M Talamonti, M Galluzzo, A Chiricozzi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 26, 2024
Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study
C Bonifati, S Lembo, A G Richetta, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 19, 2024
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment
C C Zouboulis, F G Bechara, F Benhadou, et al.
The Journal of Dermatological Treatment
|
August 20, 2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)
D Orsini, M Megna, C Assorgi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 9, 2024
Real-life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24-week Italian study
B M Piraccini, F Pampaloni, S Cedirian, et al.
Page
of 7